Interface between science and art: can art predict functions of enzymes? by Clemenz, C
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2009
Interface between science and art: can art predict functions of
enzymes?
Clemenz, C
Clemenz, C. Interface between science and art: can art predict functions of enzymes? 2009, University of Zurich,
Vetsuisse Faculty.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
University of Zurich, Vetsuisse Faculty, 2009.
Clemenz, C. Interface between science and art: can art predict functions of enzymes? 2009, University of Zurich,
Vetsuisse Faculty.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
University of Zurich, Vetsuisse Faculty, 2009.
Institut für Veterinärbiochemie und Molekularbiologie 
der Vetsuisse-Fakultät Universität Zürich 
 
Direktor: Prof. Ulrich Hübscher 
 
 
 
 
Interface between science and art: 
 Can art predict functions of enzymes? 
 
 
 
 
Inaugural-Dissertation 
 
zur Erlangung der Doktorwürde der 
Vetsuisse-Fakultät Universität Zürich 
 
 
vorgelegt von 
 
Céline Clemenz 
 
cand. med. vet. 
von Stalden-Staldenried, VS 
 
genehmigt auf Antrag von 
Prof. Ulrich Hübscher, Referent 
Prof. Hanspeter Nägeli, Korreferent 
 
 
Zürich 2009 

31. SUMMARY............................................................................................................................ 4 
1.1 ENGLISH ............................................................................................................................... 4 
1.2 GERMAN ............................................................................................................................... 5 
2 INTRODUCTION.................................................................................................................... 6 
2.1 DNA STABILITY, THE CELL CYCLE AND DNA DAMAGE CHECKPOINTS ......................................... 6 
2.2 DNA REPAIR ......................................................................................................................... 7 
2.2.1 Base excision repair (BER) .............................................................................................. 7 
2.2.2 Non-homologous end joining (NHEJ) .............................................................................. 8 
2.3 DNA POLYMERASE  ........................................................................................................... 10 
2.3.1 Structure and function of human DNA polymerase ..................................................... 10 
2.3.2 DNA polymerase  and 7,8 dihydro-8-oxoguanine (8-oxo-G)........................................ 12 
2.3.3 DNA polymerase  in DNA repair processes ................................................................. 13 
2.4 THE „METASYSTEM PERZAN“................................................................................................ 14 
2.4.1 iGENE VISIONS............................................................................................................. 14 
2.4.2 PerZan references ......................................................................................................... 15 
3 AIM AND PROJECT DESCRIPTION .................................................................................. 16 
4 MATERIALS AND METHODS ............................................................................................ 17 
4.1 BUFFERS AND SOLUTIONS .................................................................................................... 17 
4.2 PROTEINS ........................................................................................................................... 19 
4.2.1 DNA polymerase , wild type ......................................................................................... 19 
4.2.2 DNA polymerase , mutants .......................................................................................... 19 
4.2.3 Bovine serum albumin ................................................................................................... 20 
4.3 ANTIBODIES ........................................................................................................................ 20 
4.3.1 Anti-His antibody selector kit.......................................................................................... 20 
4.3.2 Secondary antibody ....................................................................................................... 20 
4.4 DNA SUBSTRATES, PRIMERS, TEMPLATES............................................................................. 20 
4.4.1 39/72 mer and 39/8oxoG72 mer primer/template for DNA polymerase assays ............ 20 
4.5 WESTERN BLOT ANALYSIS .................................................................................................... 21 
4.6 SITE-DIRECTED MUTAGENESIS.............................................................................................. 21 
4.7 PLASMID PURIFICATION ........................................................................................................ 22 
4.8 PROTEIN PURIFICATION........................................................................................................ 22 
4.9 PREPARATION OF RADIOLABELED PRIMER/TEMPLATES ........................................................... 24 
4.10 DNA POLYMERASE ASSAY.................................................................................................. 24 
4.11 NUCLEASE ASSAY .............................................................................................................. 25 
5 RESULTS ............................................................................................................................ 27 
5.1 RATIONALE TO DESIGN IN SILICO MUTANTS OF DNA POLYMERASE ........................................ 27 
5.2 ANALYSIS OF 20 DNA POLYMERASE  MUTANTS BY THE „METASYSTEM PERZAN” .................... 30 
5.3 CHARACTERIZATION OF THE FOUR DNA POLYMERASE  MUTANTS AFTER PURIFICATION .......... 31 
5.4 TITRATION OF THE FOUR DNA POLYMERASE  MUTANTS ON A 39/72 MER PRIMER/TEMPLATE... 32 
5.5 TITRATION OF THE FOUR DNA POLYMERASE  MUTANTS ON A 39/8OXOG72 MER 
PRIMER/TEMPLATE..................................................................................................................... 33 
5.6 TITRATION OF THE FOUR DNA POLYMERASE  MUTANTS ON 39/72 MER AND ON 39/8OXOG72 
MER PRIMER/TEMPLATES............................................................................................................ 34 
5.7 TITRATION OF dNTP'S IN THE PRESENCE OF A CONSTANT AMOUNT OF THE FOUR DNA 
POLYMERASE  MUTANTS ON 39/72 MER AND ON 39/8OXOG72 MER PRIMER/TEMPLATES .............. 37 
5.8 SINGLE NUCLEOTIDE dCTP AND dATP TITRATIONS OF THE FOUR DNA POLYMERASE  MUTANTS 
ON 39/72 MER AND ON 39/8OXOG72 MER PRIMER/TEMPLATES .................................................... 40 
6 DISCUSSION....................................................................................................................... 44 
7 REFERENCES..................................................................................................................... 46 
8 ACKNOWLEDGEMENTS.................................................................................................... 50 
9 CURRICULUM VITAE ......................................................................................................... 51 
41. Summary 
1.1 English 
The aim of this study was to scientifically verify predictions based on the 
„metasystem PerZan”. For this purpose 20 DNA polymerase (pol)  mutants, 
generated in silico, were analyzed by Karsten Knut Panzer with his 
„metasystem PerZan”. According to his predictions, these 20 mutants were 
subdivided into five classes of mutational success, whereof four different 
mutants have been chosen. These pol  mutants were produced by site-
directed mutagenesis, cloned in E. coli, expressed and purified. They were 
subjected to scientific verification. Firstly, different titrations were done over a 
control (39/72 mer) and an 8-oxo-G lesion (39/8oxoG72 mer) primer/template. 
According to the titration of the mutant pol  enzymes over these 
primer/templates the mutants were ranked referring to their activity and 
efficiency. Secondly, the same was done by titrating dNTPs. The results 
indicated that K312V was the most active and efficient mutant, followed by 
Y267W and A349P; D490K was inactive. That order was also predicted by the 
„metasystem PerZan”. With single nucleotide titration over the same 
templates an other order was found, namely that the mutant A349P was 
better incorporating the correct dCTP than the wild type (WT), followed by 
Y267W, K312V and D490K. In summary, this thesis study suggested that the 
„metasystem PerZan” might give a valuable overview, but more work is 
needed to verify the „PerZan hypothesis” as a predictable way to suggest 
protein functions in biology and medicine.  
51.2 German 
Das Ziel dieser Studie war es Voraussagen, die durch das „Metasystem 
PerZan“ gemacht wurden, wissenschaftlich zu überprüfen. Dazu wurden 20 
DNA-Polymerase (pol)  Mutanten in silico generiert und von Karsten Knut 
Panzer mit seinem „Metasystem PerZan“ analysiert. Anhand seiner 
Vorhersagen wurden diese 20 pol  Mutanten in fünf Klassen von 
„Mutationserfolgen” eingeteilt, wovon vier Mutanten ausgewählt wurden. 
Diese pol  Mutanten dienten zur wissenschaftlichen Überprüfung. Durch 
gezielte Mutagenese wurden die pol  Mutanten hergestellt, in E. coli kloniert, 
exprimiert, gereinigt und analysiert. Erstens wurden die pol  Enzyme an 
einer Kontroll (39/72 mer) und einer 8-oxo-G (39/8oxoG72) Primer/Matrize 
titriert. Anhand der Ergebnisse wurden die pol  Mutanten nach ihrer Aktivität 
und Effizienz geordnet. Zweitens wurde dasselbe gemacht für die 
dNTPtitration. Es zeigte sich, dass K312V die aktivste und effizienteste 
Mutante war, gefolgt von Y267W und A349P. D490K war inaktiv. Diese 
Reihenfolge wurde auch vom „Metasystem PerZan“ vorhergesagt. Mit der 
Einzelnukleotidtitration an denselben Primer/Matrizen wurde eine andere 
Reihenfolge gefunden. Die Mutante A349P baute das korrekte dCTP besser 
ein als der Wildtyp, gefolgt von Y267W, K312V und D490K. 
Zusammenfassend konnte gezeigt werden, dass das „Metasystem PerZan“ 
einen Überblick geben kann. Weitere Studien sind notwendig, um die „PerZan 
Hypothese“ als Voraussage für Proteinfunktionen in Biologie und Medizin zu 
etablieren. 
 
62 Introduction 
2.1 DNA stability, the cell cycle and DNA damage 
checkpoints 
All the genetic information that enables a cell to develop, to divide and to react 
to its environment is stored in the DNA, which is mainly located in the cell 
nucleus. The maintenance of genome integrity is essential for the proper 
function and survival of all organisms. This task is particularly daunting due to 
constant assault on the DNA by endogenous and exogenous factors. DNA 
damage, due to environmental factors and normal metabolic processes inside 
the cell, occurs at a rate of 1,000 to 1,000,000 molecular lesions per cell and 
day (Lodish and Darnell, 1995). Sources for endogenously caused DNA 
damage may be firstly oxidation, for example due to reactive oxygen species 
(ROS) generated as normal metabolic byproducts. Secondly, spontaneous 
base loss due to hydrolysis of the chemically instable N-glycosilic bond and 
thirdly by alkylation or non-enzymatic methylation (Lindahl, 1993). 
Furthermore also the infidelity of certain DNA polymerases (pols) can lead to 
misincorporation of dNTPs during DNA replication and repair. On the other 
hand sources for exogenous DNA damages are for example ionizing radiation 
(IR), ultraviolet (UV) radiation and various chemical agents. 
To guarantee survival, a cell has to be able to replicate its DNA correctly and 
to repair the damages, in order to maintain the sequence and structure of this 
crucial molecule stable and active physiological ranges over the entire 
lifespan. Over billions of years of evolution many different strategies have 
evolved in order to make a cell able to respond to those two tasks of 
replication and repair in the most efficient way possible. Only the most 
successful strategies have been conserved over this vast time span by being 
constantly inherited to the subsequent cell generations.  
The cellular response to DNA damages may involve activation of a cell cycle 
checkpoint, commencement of transcriptional programs, execution of DNA 
repair or when the damage is severe, initiation of apoptosis. 
 
7The cell cycle is divided into the four phases: G1 (gap 1) as the phase of the 
cells normal activity state, followed by the S-phase (synthesis), representing 
the period in which the DNA is copied. Afterwards, the cell enters the G2-
phase (gap 2), an important phase to enable preparation and initiation of cell 
division and finally the M-phase (mitosis), in which the cell divides itself in two 
identical daughter cells. As a fifth stage the G0-phase (gap 0), a steady 
equivalent of the G1-phase, represents the state of the cells that have 
undergone full differentiation and cannot divide further under normal 
circumstances. 
This cell cycle progression is strongly regulated and surveyed by so called cell 
cycle checkpoints. By means of highly sophisticated pathways that can be 
activated at those checkpoints, the cell surveys the progression of every 
phase of the cycle, even under severe circumstances. The cellular response 
provoked by DNA damage consists of slowing down the cell cycle and stalling 
it completely at the G2/M transition (Foiani et al., 2000), to provide the 
necessary time to repair damage through multiple different DNA repair 
pathways (Christmann et al., 2003). These mechanisms include base excision 
repair (BER), nucleotide excision repair (NER), mismatch repair (MMR) and 
double-strand break repair (DSBR).  
2.2 DNA repair 
As mentioned above, there are several mechanisms of repair. Pol , which is 
the main focus of this study, is mainly involved in BER and NHEJ (Ramadan 
et al., 2004).  
2.2.1 Base excision repair (BER) 
Base excision repair is a multi-step process that corrects non-bulky damage 
to bases resulting from oxidation, methylation, deamination or spontaneous 
loss of the DNA base itself (Memisoglu and Samson, 2000). These 
alterations, although simple in nature, are highly mutagenic and therefore 
represent a significant threat to genome fidelity and stability (Friedberg et al., 
1995). 
8BER consists of two sub-pathways, both of which are initiated by the action of 
a DNA glycosylase that cleaves the N-glycosidic bond between the damaged 
base and the sugar phosphate backbone of the DNA. This cleavage 
generates an apyrimidinic/apurinic (AP) or an abasic site in the DNA. Eight 
DNA glycosylases with partially overlapping base adduct specificity have been 
identified in humans (Maya et al., 2001). Alternatively, AP sites can also arise 
by the spontaneous hydrolysis of the N-glycosidic bond. In either case, the AP 
site is subsequently processed by AP endonuclease 1 (APE1) which cleaves 
the phosphodiester backbone immediately 5' to the AP site, giving rise to a 3' 
hydroxyl group and a transient 5' abasic deoxyribose phosphate (dRP). 
Removal of the dRP can amongst others be accomplished by the action of pol 
, which adds one nucleotide to the 3' end of the nick and removes the dRP 
moiety via its associated AP lyase activity (Matsumoto and Kim, 1995). The 
strand nick is finally sealed by DNA ligase lll (and XRCC1), thus restoring the 
integrity of the DNA. Replacement of the damaged base with a single new 
nucleotide as described above is referred to as „short-patch” repair and 
represents approximately 80-90% of all BER events. 
The back-up pathway of BER, termed „long-patch” repair, is employed when a 
modified base resistant to the AP lyase activity of pol  is present in the DNA 
(Matsumoto et al., 1994). Long-patch BER results in the replacement of 
approximately 2-10 nucleotides including the damaged base. This sub-
pathway requires many of the same factors involved in short-patch repair, 
including a DNA glycosylase, APE1 and pol . Unlike short-patch repair, 
however, long-patch repair is a PCNA-dependent pathway (Frosina et al., 
1996), where the pol  or  add several nucleotides to the repair gap thus 
displacing the dRP as part of a "flap" oligonucleotide. The resulting 
oligonucleotide overhang is excised by the Flap endonuclease (FEN-1) prior 
to sealing of the nick by DNA ligase I. 
2.2.2 Non-homologous end joining (NHEJ) 
In addition to altered bases, DNA can also encounter double-strand breaks 
(DSBs), which are perhaps the most serious form of DNA damage because 
they pose problems for transcription, replication, and chromosome 
9segregation. Damage of this type is caused by a variety of sources including 
ionizing radiation and certain genotoxic chemicals, endogenously generated 
ROS, replication of single-strand DNA breaks, and mechanical stress on the 
chromosomes (Lindahl, 1993). DSBs differ from most other types of DNA 
lesions in that they affect both strands of the DNA duplex and therefore 
prevent use of the complementary strand as a template for repair. Failure to 
repair these defects can result in chromosomal instabilities leading to 
disregulated gene expression and carcinogenesis (Hoeijmakers, 2001). To 
counteract the detrimental effects of these potent lesions, cells have evolved 
two distinct pathways of DSBR (Jackson, 2002), namely homologous 
recombination (HR) and NHEJ. The cellular decision as to which pathway to 
utilize for DSBR is unclear, however, it appears to be largely influenced by the 
stage of the cell cycle at the time of damage acquisition (Takata et al., 1998). 
Generally HR occurs during the S-phase of the cell cycle. 
NHEJ is particular in that aspect as that it does not require a homologous 
template for DSBR and usually results in the correction of the break in an 
error-prone manner. Essential to the NHEJ pathway is the activity of the 
Ku70/Ku80 heterodimeric protein (Featherstone and Jackson, 1999). The Ku 
heterodimer initiates NHEJ by binding to the free DNA ends and recruiting 
other NHEJ factors such as DNA-dependent protein kinase (DNA-PK), 
XRCC4, and DNA Ligase IV to the site of injury (Jackson, 2002). DNA-PK 
becomes activated upon DNA binding, and phosphorylates a number of 
substrates including p53, Ku, and the DNA Ligase IV cofactor XRCC4. 
Phosphorylation of these factors is believed to further facilitate the repair 
process. Because the ends of most DSBs generated by genotoxic agents are 
damaged and therefore unable to be directly ligated, they often have to 
undergo limited resection by nucleases and synthesis by pols before NHEJ 
can be executed. The nuclease(s) responsible for this processing remains to 
be determined, but strong candidates for this activity include the 
MRE11/Rad50/NBS1 complex (Haber, 1998; Petrini, 2000), FEN-1 (Wu et al., 
1999) and the Artemis protein (Moshous et al., 2001). The final step in NHEJ 
repair involves ligation of the DNA ends by Ligase IV in a complex that also 
includes XRCC4 and Ku. 
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2.3 DNA polymerase   
2.3.1 Structure and function of human DNA polymerase    
Pols are template-directed enzymes, catalyzing phosphoryl transfer reactions 
(Hubscher et al., 2002). Their role lies in the synthesis of long polymers of 
nucleotide monophosphates, whose linear addition dictated by the sequence 
of the complementary template DNA strand (Kelman and O'Donnell, 1994). 
The structure of pols has been optimized through evolution to suit the 
specialized tasks that each pol faces within its environment. Among the about 
20 DNA pols known in an animal cell, the one that draws the attention to this 
work is pol . 
Human pol  belongs to the family X member pols (Hubscher et al., 2002). In 
the last 10 years, a large number of studies have provided a wealth of 
structural information on five family X members. They are (i) pol  (Beard et 
al., 2002), (ii) terminal deoxyribonucleotidyl transferase (Delarue et al., 2002), 
(iii) pol  (Ramadan et al., 2004), (iv), pol μ (Garcia-Diaz et al., 2004) and (v) 
the African Swine Fever virus pol X (Maciejewski et al., 2001; Showalter et al., 
2001). 
Pols share a common overall structure resembling a right hand with three 
domains: the fingers, the palm and the thumb (Steitz, 1999). The structural 
studies of pol  and other pols has led to a model for the catalytic cycling 
during polymerization: polymerization begins with DNA binding followed by 
dNTP binding, which might trigger a conformational change from an inactive, 
closed conformation to an active, open one. In this regard pol  is special in 
that it also seems to exist in a closed, but active conformation, even though 
no dNTP is bound to the active site of the pol (Garcia-Diaz et al., 2004). In 
summary it seems that the active site of pol  is different from other pols 
studied so far. 
The 575 amino acid polypeptide of human pol  comprises an N-terminal 
BRCT domain, the catalytic core and a serine-proline rich region connecting 
the two (Garcia-Diaz et al., 2005). The catalytic core consists of three 
subdomains that have been linked to the fingers (residues 328-385), the palm 
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(residues 386-494) and the thumb (residues 495-575) of a right hand (Steitz, 
1999). The 8kDa region (residues 249-327), containing the dRP lyase activity, 
is situated on the 39kDa catalytic core domain (Figure 1A) on the N-terminus. 
Thus pol  shares the modular organization characteristic of X family 
enzymes. 
 
Figure 1: Domain and subdomain organization of DNA polymerase . A) Linear 
diagram indicating the different domains that compose the full-length pol  protein: 
BRCT, serine-proline rich domain (S-P), 8kDa domain and the pol catalytic domain, 
composed of fingers, palm and thumb subdomains. B) Ribbon representation of the 
39kDa catalytic core of pol  in complex with a two-nucleotide gap (the DNA is shown 
in stick representation). The molecular surface is shown in transparent gray. The 
different subdomains are color coded as in A). Reproduced from (Garcia-Diaz et al., 
2005). 
BRCT domains are generally involved in protein-protein interactions between 
factors required for the cellular response to DNA damage. BRCT is 
associated with processing of DNA ends during NHEJ of DSBs resulting from 
DNA damage, and /or during V(D)J recombination (Lee et al., 2004). The 
serine-proline rich region connects the BRCT domain to the catalytic core 
(Garcia-Diaz et al., 2005) and has been suggested to be a target for 
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posttranslational modifications (Garcia-Diaz et al., 2000). The catalytic core is 
finally composed of a N-terminal 8kDa domain unique to family X pols and a 
pol domain, including the fingers, the palm containing the catalytic 
carboxylates, and the thumb subdomains that are common to all pols (Steitz, 
1999). The function of the palm domain appears to be the catalysis of the 
phosphoryl transfer reaction whereas that of the fingers domain includes 
important interactions with the incoming nucleoside triphosphate as well as 
the template base to which it is paired. The thumb on the other hand may play 
a role in positioning the duplex DNA and in processivity and translocation 
(Steitz, 1999). The 8kDa domain includes the dRP lyase activity which can 
remove a 5’ terminal sugar-phosphate (dRP) group (Garcia-Diaz et al., 2001). 
This is consistent with a possible role for pol  in BER (Garcia-Diaz et al., 
2002).  
2.3.2 DNA polymerase   and 7,8 dihydro-8-oxoguanine (8-oxo-G) 
The production of ROS, such as hydrogen peroxide, superoxide and hydroxyl 
radicals, has been linked to the initiation and progression of cancer (Klaunig 
and Kamendulis, 2004). ROS are by-products of cellular respiration in 
mitochondria and components of inflammatory responses. In addition, ROS 
can be produced as a consequence of ionizing radiation or environmental 
exposure to transition metals, chemical oxidants and free radicals. Normal 
cells have enzymatic and non-enzymatic mechanisms to counteract the 
production of ROS. On the other hand aberrantly functioning cells are often in 
a state of „oxidative stress“, in which the balance between oxidants and 
antioxidants has been disrupted, resulting in increased levels of cellular 
damage and thus the risk for cancer.  
DNA bases are particularly susceptible to oxidation mediated by ROS (Neeley 
and Essigmann, 2006). The low redox potential of guanine makes this base 
particularly vulnerable and leads to a plethora of oxidized guanine products 
(Neeley and Essigmann, 2006). The most thoroughly examined guanine 
oxidation product is 7,8-dihydro-8-oxoguanine (8-oxo-G) (Burrows and Muller, 
1998; Neeley and Essigmann, 2006). Base-excision repair plays an important 
role in repairing those mutations (David et al., 2007). In our laboratory it has 
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been shown in 2007 that pol  might be a protection shield against these 
oxidative damages, since it can incorporate the correct C opposite an 8-oxo-G 
and thus corrects the mistakes made by the replication machinery, which 
often incorporates the wrong A opposite an 8-oxo-G (Maga et al., 2007). Pol 
, PCNA and RP-A together allow correct incorporation of dCTP opposite an 
8-oxo-G template 1,200-fold more efficiently than the incorrect dATP. 
Experiments with pol--null cell extracts supported this important role for pol  
(Maga et al., 2008; Maga et al., 2007). For this reason the focus of this thesis 
work was on pol  and 8-oxo-G damage. 
2.3.3 DNA polymerase   in DNA repair processes 
It has been well documented that the polymerase and dRP lyase activities of 
mammalian pol  participate in single short patch BER (Sobol and Wilson, 
2001). Since pol  can fill in short gaps, has a dRP lyase activity and can 
substitute or pol  in a reconstituted in vitro BER reaction (Sobol and Wilson, 
2001) it has been proposed that pol  may also participate in some form of 
BER. Support for this hypothesis comes from two studies implicating pol  in 
BER (Braithwaite et al., 2005a; Braithwaite et al., 2005b).  
In addition to its involvement in BER, pol  has been implicated in NHEJ (Fan 
and Wu, 2004; Lee et al., 2004; Ma et al., 2004). The ability of pol  to 
participate in NHEJ is clearly dependent on the presence of its BRCT domain, 
which enables the enzyme to interact with other end-joining proteins (Ma et 
al., 2005; Nick McElhinny and Ramsden, 2004; Rooney et al., 2004). 
However, besides this basic requirement, there is growing evidence 
suggesting that NHEJ pols have special properties enabling them to conduct 
synthesis on the non-canonical substrates that are encountered during NHEJ 
repair. For instance, an important feature of gap filling in the context of NHEJ 
may be the capacity of the pol  8kDa domain to bridge the gap by binding to 
its 5’ end (Garcia-Diaz et al., 2005). 
In summary pol  appears to be involved in short-patch BER, in BER over 8-
oxo-G and in NHEJ. 
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2.4 The „metasystem PerZan“ 
2.4.1 iGENE VISIONS 
Science and art are in the current issue of debate often dominated by 
misunderstandings and the non-willingness to try to understand each other. 
These differences could be considered as reconciled if one were prepared to 
realize and evaluate the ever-increasing complexity of „worldviews” and 
„viewed worlds”. 
In an attempt to penetrate and combine these highly complex systems, there 
is a need for an interdisciplinary „meta-language”, a connecting and bridging 
grammar of natural science and aesthetics, a general regulatory system that 
defines the interface between physical, biological and mental structures. The 
„metasystem PerZan” tries to offer such a design and uses the scientific 
methodology in combination with the aesthetic experience. 
This synthesis-study and structural work is based on binaryly formulated 
representatives of two (central) culture hemispheres: on one hand on 
hemisphere with its western rational and biological code of the DNA and its 
dualism of the base pairs, A-T and G-C. On the other hand there is the 
eastern hemisphere with its idealistic yin-yang-polarity of the archaic „I-Ging” 
from the Chinese „Book of Changes”. Although the two systems hold 
admittedly diverse but quite possibly harmonizable items, they gradually 
provide instructions for an extensive transfer of knowledge between the two 
systems. This also means that the confrontation of between western and 
eastern perception and cognition almost entirely moves along with the 
analysis of the contrast between science and art. 
The „metasystem PerZan” uses the polarity of the Chinese trigrams in which 
unbroken lines stand for the Yang = 0 and broken lines represent the Yin = 1 
principles, thereby symbolizing the active powers of the 8 natural elements 
heaven, earth, fire, water, mountain, sea, thunder and wind. Out of 2 of these 
8 elements, it is possible to form so-called hexagrams which are in fact the 
actual carriers of the information in content, and which are then used as 
binary reading-frames for the just as archaic but biological test of the DNA. In 
analogy the formal construction of the eastern system is represented by 64 
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components of the genetic alphabet which give rise to the 64 nucleic acids 
triplets which themselves are encoded by the already mentioned 
complementary base pairs, A-T and G-C, but also from the biochemical 
„binary” arrangement of purines and pyrimidines. 
The project iGENE (I-Ging + Genes) VISIONS was taken up 15 years ago by 
Karsten Knut Panzer, a German artist, to study whether these complex 
structures which are identical, can also lead to a functional equalization, and if 
so, which regulatory system would be behind. As a mediator of such a 
transdisciplinary information-transmission, an unique color system with 2 
integrated, three-dimensional color rooms, named „color space 64 PerZan”, 
was developed by Karsten Knut Panzer, whose 3 main co-ordinates are the 
primary colors red, blue and yellow. Both, the physical color-theory as well as 
Goethe`s theory of colors are integrated, which, as a result, can be even 
confirmed from a new perspective.  
Each of these 64 single cubes in the color-space 64 PerZan represents three 
functioning units of (i) the primary-color composed colors as a physical, (ii), a 
genetic amino acid as biochemical and (iii) a Chinese hexagram as a non-
material functioning unit. According to the type of question and its result, the 
color space 64 could now function as a universal transfer- and synthesis-
room. 
Based on this metasystem combining genetics and art, the „metasystem 
PerZan” was making predictions of the „mutation success” for pol . 
2.4.2 PerZan references 
The following four references can be found in www.perzan.de. 
www.perzan.de: Karsten K. Panzer PerZan (2001). CONSEQUENZEN 
www.perzan.de: Karsten K. Panzer PerZan (2000). I GENE VISIONS 
www.perzan.de: Karsten K. Panzer PerZan (1999). LIFE – CODES. VON 
GEIST & GENEN. 
www.perzan.de: Karsten K. Panzer PerZan. WENN DIE GENE TRAUER 
TRAGEN. 
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3 Aim and project description 
 
The aim of this study was to scientifically verify predictions made based on 
the „metasystem PerZan”. Therefore, firstly the structure and the functions of 
pol  as well as its interaction with the DNA were studied in silico. Taking this 
as a starting point, 20 different mutations in the nucleotide sequence of pol  
were proposed, which may have or may not have an influence on structure 
and/or function. The reason for focusing on pol  was that this enzyme was 
shown in our laboratory to be 1,200 times more efficiently in incorporating a 
correct dCTP opposite an 8-oxo-G site in the presence of PCNA and RP-A.  
The 20 pol  mutants, generated in silico, were analyzed by Karsten Knut 
Panzer on the basis of his „metasystem PerZan”. According to this, the 
mutants were subdivided into five classes of mutational success, whereof 
subsequently have been chosen four mutants of different classes. They 
should be subjected to scientific verification by testing them on different 
primer/templates, namely on a control and on an 8-oxo-G template. 
Finally the obtained scientific results should be compared to the predictions 
made by the „metasystem PerZan”. 
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4 Materials and methods 
4.1 Buffers and solutions 
CaCl2 (containing 15% glycerol): 
(preparation of competent cells) 
100 mM CaCl2 
[15% (v/v) glycerol] 
 
Resolving gel buffer for SDS 
PAGE: 
1.5 M Tris-Base 
0.4% (w/v) SDS 
dissolved in ddH20, adjusted to pH 
8.8 with HCl 
   
SDS PAGE Running buffer: 
125 mM Tris-Base 
1 M glycine 
0.5% (w/v) SDS 
dissolved in ddH20 
 
Stacking gel buffer: 
0.5 M Tris-Base 
0.5% (w/v) SDS 
dissolved in ddH20, adjusted to pH 
6.8 with HCl 
   
PCR-mix: 
10 μl of 5x Phusion HF Buffer 
10 mM each of dNTP, final 
concentration 200 μM each 
10 μM of oligonucleotide primer 
forward 
10 μM of oligonucleotide primer 
reverse 
5 ng/μl dsDNA (pRSETb-hpol ) 
1 μl PhusionTM High-Fidelity DNA 
polymerase, 0.02 U/μl 
ddH2O to a final volume of 50 μl 
 
Buffer A: 
(for pol  purification) 
50 mM Tris-HCl, pH 7.5 
10% (v/v) glycerol 
0.05% (v/v) NP-40 
1 mM PMSF 
1 μg/ml pepstatin 
1 μg/ml leupeptin 
1 μg/ml bestatin 
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Buffer B: 
(for pol  purification) 
50 mM Tris-HCl, pH 7.5 
150 mM NaCl 
10% (v/v) glycerol 
0.05% (v/v) NP-40 
10 mM Imidazol 
1 mM PMSF 
1 μg/ml pepstatin 
1 μg/ml leupeptin 
1 μg/ml bestatin 
 
Buffer C: 
(for pol  purification, dialysis 
buffer) 
20 mM Tris-HCl, pH 7.5 
20% (v/v) glycerol 
100mM NaCl 
1 mM DTT 
 
   
TBST buffer: 
10 mM Tris-HCl, pH 7.5 
50 mM NaCl 
0.1% (v/v) Tween 
 
Blocking buffer: 
2.5% (w/v) milk powder in TBST 
   
TBE buffer (10x):  
900 mM Tris-Base 
900 mM boric acid 
20 mM EDTA 
 
TBS buffer: 
10 mM Tris-HCl, pH 7.5 
50 mM NaCl 
   
Lämmli buffer (2x): 
500 mM Tris pH 7.5 
4% (w/v) SDS 
20% (v/v) glycerol 
40 mM DTT 
0.02% (w/v) bromphenol blue 
 
Transfer buffer: 
25 mM Tris-Base 
192 mM glycine 
20% (v/v) methanol 
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Coomassie destaining solution: 
10% (v/v) acetic acid 
10% (v/v) isopropanol 
dissolved in H2O 
 
Coomassie staining solution: 
10% (v/v) acetic acid 
0.25% (w/v) Coomassie Blue R250 
40% (v/v) methanol 
   
Annealing buffer (5x): 
100 mM Tris-HCl, pH 7.4 
750 mM NaCl 
 
 
S  buffer (10x): 
500 mM Tris-HCl, pH 7.5 
2.5 mg/ml BSA 
10 mM DTT 
   
Stop buffer (2x): 
96% formamide 
20 mM EDTA, pH 8.0 
bromophenol blue 
xylene cyanol 
  
 
4.2 Proteins 
4.2.1 DNA polymerase  , wild type 
The DNA pol  WT protein was cloned, transfected, expressed and purified 
according to (Wimmer et al., 2008). (For details see 4.8.) 
4.2.2 DNA polymerase  , mutants 
The A349P, K312V, Y267W and D490K pol  mutants were generated with 
site-directed mutagenesis according to the protocol of Garcia-Diaz (Garcia-
Diaz et al., 2000). In short the DNA (dsDNA) vector with the target site for 
mutation was denaturated and the two oligonucleotides primers (reverse and 
forward), containing the desired mutation, annealed. Using the nonstrand-
displacing action of DNA pol, extend and incorporate the mutagenic primers 
resulting in nicked circular strands. The methylated, nonmutated parenteral 
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DNA template was digested with Dpn1. After that the circular, nicked dsDNA 
was transformed in DH5 cells. The protein was generated in BL21(DE3) 
competent E. coli bacterias. The cloned protein was expressed and purified 
as described in (Wimmer et al., 2008). (For details see 4.8.) 
4.2.3 Bovine serum albumin  
Bovine serum albumin (BSA) was purchased from New England Biolabs. 
4.3 Antibodies 
4.3.1 His antibody selector kit 
The Anti-His Antibody Selector Kit from Qiagen recognizes 4xHis-tagged 
proteins. The pol  WT as well as the A349P, K312V, Y267W and D490K pol 
 mutants were N-terminally 6xHis-tagged. 
4.3.2 Secondary antibody 
The Anti-mouse IgG was obtained from Amersham Biosciences. 
4.4 DNA substrates, primers, templates  
4.4.1 39/72 mer and 39/8oxoG72 mer primer/template for DNA 
polymerase assays 
The control d72 mer, the d72 mer with the 8-oxo-G lesion and the 
corresponding primers were chemically synthesized and purified on 
denaturing polyacrylamide gel (Maga et al., 2002). The sequences are as 
follows: 
72 mer (template): 
5`-GTA TTA GAT ATT CGG GAG GTT GGG CGC CGG CGG[X/G] TGT GAA 
TTC GGC ACT GGC CGT CGT ATG CTC TTG GTT GTA-3` 
72 mer (template) with 8-oxo-G lesion: 
The position of the lesion in the undamaged template is indicated in brackets 
(X = 8-oxo-G). 
39 mer (primer): 
5`-TAC AAC CAA GAG CAT ACG ACG GCC AGT GCC GAA TTC ACA- 3` 
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4.5 Western blot analysis 
Proteins were separated on a 12% SDS-PAGE [40% stock solution
Acrylamide/Bis, solution (37.5:1), (Serva)] and electroblotted for 1.5 h at 120V 
(BioRad Western Blot apparatus) onto Nitrocellulose Membran (Immobilon) in 
transfer buffer at 4°C. After blocking the membranes for 45 min in TBST 
containing 2.5% powdered Milk, the membranes were incubated with the 
appropriate antibodies, diluted in TBST, for 2 h at room temperature. Then the 
membranes were washed 3 times 10 min in TBST and incubated with the 
corresponding secondary antibodies, diluted in TBST, for 1 h at room 
temperature. This was followed by washing again 3 times 10 min in TBST. 
The antibodies bound to the membranes were detected by Uptilight HRP blot 
Reagent A (Uptima) or SuperSignal West Dura Extendent Duration Substrate 
(Pierce). 
4.6 Site-directed mutagenesis 
Site-directed mutations were preformed according to the protocol of the 
QuikChangeTM Site-Directed Mutagenesis Kit. The mutations were introduced 
into a human pol  overexpression plasmid (pRSETb-hpol ) by a PCR-based 
method with the following oligonucleotides: A349P-forward: 5`-GCT GGG 
ACC AAG ACT CCC CAG ATG TGG TAC CAA CAG; A349P-reverse: 5`-
CTG TTG GTA CCA CAT CTG GGG AGT CTT GGT CCC AGC; K312V-
forward: 5`-GGG AAG CGG ATG GCT GAG GTA ATC ATA GAG ATC CTG 
GAG; K312V-reverse: 5`-CTC CAG GAT CTC TAT GAT TAC CTC AGC CAT 
CGG CTT CCC; Y267W-forward: 5`-CTG GAA GTT CTG GCC AAA GCC 
TGG AGT GTT CAG GGA GAC AAG TGG; Y267W-reverse: 5`-CCA CTT 
GTC TCC CTG AAC ACT CCA GGC TTT GGC CAG AAC TTC CAG; D490K-
forward: 5`-CAC CGG CGC CTG AAG ATC ATC GTG GTG CCC; D490K-
reverse: 5`-GGG CAC CAC GAT GAT CTT CAG GCG CCG GTG. The first 
segment of the PCR was done with 98°C for 30s. The second segment was 
started with 98°C for 30 s, followed by 82°C (A349P), 70°C (K312V, Y267W), 
68°C (D490K) for 1 min and 72°C for 1.5 min. The PCR was finished at 72°C 
for 5 min. The PCR products were digested with Dpn1 for 60 min at 37°C. 
Phusion buffer and polymerase used for PCR were from Finnzyme. 
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Purification of A349P, K312V, Y267W and D490K pol  mutant plasmids was 
performed with NulceoBond plasmid purification kit and sequencing done by 
Microsynth.  
4.7 Plasmid purification 
The plasmid purification was performed according to the manufactors 
instructions (NucleoBond plasmid purification, high copy plasmid purification 
by Macherey-Nagel). The buffers S1 + RNase A, S2, S3, N2, N3 and N5 are 
specified in these instructions. 
An overnight culture (LB medium, antibiotic, a single colony picked) was 
centrifuged at 6,000 x g for 15’ at 4°C. The pellet was resuspended in 4 ml 
buffer S1 + RNase A. Afterwards 4 ml buffer S2 was added and the mixture 
was incubated at room temperature for 2.5 min. Further 4 ml pre-cooled buffer 
S3 were added and the suspension incubated on ice for 5’. At the same time 
the column (NucleoBond AX 100) was equilibrated with 2.5 ml buffer N2. 
After that, the suspension was loaded in a filter on the column and the 
plasmid DNA was bound. Then the column was washed with 10 ml buffer N3 
and the plasmid DNA was eluted with buffer N5 and was caught in 3.5 ml 
room-temperature isopropanol and centrifuged at 4,000 x g for 30’ at 4°C. 
Further 2 ml 70% ethanol were added to the pellet, vortexed and centrifuged 
4,000 x g for 15’ at 4°C. The pellet was allowed to dry at room temperature for 
30’. At the end the DNA pellet was dissolved in 50 μl buffer TE and stored at -
20°C. 
4.8 Protein purification 
The purification procedure for pol  WT and mutants was optimized in our lab 
(Wimmer et al., 2008). 
1 l of transformed E. coli BL21(DE3) cells were grown at 37°C to an A600 of 
0.6 in LB medium supplemented with 100 μg/ml ampicillin. Expression of 
human His-pol  WT and mutant proteins was induced with 1 mM IPTG for 3 
h and the cells were subsequently pelleted. All purification steps were carried 
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out at 4°C. Cells were resuspended in 60 ml buffer A supplemented with 500 
mM NaCl and disrupted with a French press. Insoluble material was pelleted 
by centrifugation for 30 min at 48,000 g and the supernatant was diluted to a 
final concentration of 100 mM NaCl in buffer A. The extracts from His-pol  
WT and the four mutants were each loaded onto a 15 ml phosphocellulose 
column equilibrated in buffer A containing 100 mM NaCl and rolled for 2 h at 
4°C. After washing with 5 ml column volume buffer A containing 100 mM 
NaCl, elution was performed with 60 ml buffer A containing 500 mM NaCl. 
The pooled eluate was diluted with an equal volume of buffer B and adjusted 
to 10 mM imidazol. 0.5 volumes were loaded onto a 1 ml HisTrap HP 
column (GE Healthcare) equilibrated with buffer B containing 10 mM imidazol 
using an ÄKTApurifier™ (GE Healthcare). After washing the column with 5 ml 
buffer B containing 10 mM imidazol, elution was performed using a gradient 
from 10 to 500 mM imidazol in buffer B and fractions containing His-pol  
were pooled. The resulting pool was diluted 1:3 with buffer A and loaded onto 
a 1 ml HiTrap Heparin HP column (GE Healthcare) equilibrated in buffer A 
containing 50 mM KCl. The column was washed with 5 ml buffer A containing 
100 mM KCl and eluted by using a gradient from 100 mM to 1 M KCl in buffer 
A. A final step with buffer A with 2 M KCl was performed. The fractions 
containing purified His-pol  proteins were dialyzed to buffer C and pol  WT 
and the mutants were stored in small aliquots in liquid nitrogen.  
After the purifications the proteins were tested for purity by SDS-PAGE and 
for nuclease contamination (Figure 2). 
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4.9 Preparation of radiolabeled primer/templates 
To prepare the 39/72 mer and the 39/8oxoG72 mer primer/templates, the 39 
primer was labeled at its 5`end by mixing the following reagents in a reaction 
mix of a final volume of 20 μl:  
 3.6 μM 39 mer primer (Microsynth AG) 
 20 μCi [-32P] dATP (Amersham Biosciences) 
 20 μl 10 x PNK buffer (New England Biolabs) 
 0.6 μl T4 polynucleotide kinase, 10 U/μl (New England Biolabs)  
The mix was incubated for 40 min at 37°C, the kinase inactivated for 10 min 
at 80°C and the mix centrifuged through a G-25 (Microspin TM) column at 720 
x g for 2 min to remove the free ATP. The reaction was added to the 
annealing mix containing following reagents to a final volume of 36 μl: 
 3.6 μM 72 mer or 8oxoG72 mer template (Purimex GmbH) 
 7.2 μl 5 x annealing buffer 
This mix was heated 95°C for 10 min and slowly cooled down to room 
temperature over night to allow the primer to anneal to the template. 
4.10 DNA polymerase assay 
The DNA polymerase reaction was performed in a final volume of 10 μl 
containing:  
 50 mM Tris, pH 7.5 
 250 μg/ml BSA 
 1 mM DTT 
 0.8 mM MnCl2 
 0.5 μM each of the four dNTP`s (Roche) 
 20 fmol 5`labeled 39*/72 mer or 39*/8oxoG72 mer primer/template 
 and pol  WT and mutants to be tested. 
The reaction was started by adding 9 μl of the reaction mix to pol  dilutions 
done in 1 μl and then incubated at 37°C for 15 min. Finally, 10 μl of 2 x stop 
buffer was added to each reaction tube and the reaction was put on ice. The 
samples were heated for 3 min at 95°C and loaded on to a 10% denaturing 
polyacrylamide [Acrylamide/Bis-acrylamide, 19:1 mixture, 40% (w/v) 
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(Qbiogene)] sequencing gel containing 7 M urea. The gels run on 100 watt, 
50mA and 2500 V for 2.5 h. The result was visualized by exposing the gel to a 
X-ray film (Contatyp, Typon Imaging AG) overnight at -80°C, using a 
radioactivity-sensitivity screen (Okamoto). The quantification was done with 
Adobe Photoshop CS3. 
The DNA polymerase reaction with different concentration of dNTP`s was 
performed in a final volume of 10 μl containing: 
 50 mM Tris, pH 7.5 
 250 μg/ml BSA 
 1 mM DTT 
 0.8 mM MnCl2 
 5 ng pol   WT or 10 ng pol  mutants  
 20 fmol 5`labeled 39*/72 mer or 39*/8oxoG72 mer primer/template 
 and the dNTP’s to be tested. 
The reaction was started by adding 9 μl of the reaction mix to dNTP dilutions 
done in 1 μl. Then the protocol described above was followed. 
The DNA polymerase reaction with different concentrations of dCTP`s or 
dATP`s was performed in a final volume of 10 μl containing: 
 50 mM Tris, pH 7.5 
 250 μg/ml BSA 
 1 mM DTT 
 0.8 mM MnCl2 
 2.5 ng pol  WT or 5 ng pol  mutants  
 20 fmol 5`labeled 39*/72 mer or 39*/8oxoG72 mer primer/template 
 and dCTP or dATP to be tested. 
The reaction was started by adding 9 μl of the reaction mix to dCTP of dATP 
solutions done in 1 μl. Then the protocol described above was followed, 
except that a 15%, instead of a 10%, denaturing polyacrylamide 
[Acrylamide/Bis-acrylamide, 19:1 mixture, 40% (w/v) (Qbiogene)] sequencing 
gel containing 7 M urea was used. The gels run again on 100 watt, 50mA and 
2500 V but for 4 h.  
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4.11 Nuclease assay 
The DNA nuclease assay was performed in a final volume of 10 μl containing:  
 50 mM Tris, pH 7.5 
 250 μg/ml BSA 
 1 mM DTT 
 0.8 mM MnCl2 
 20 fmol 5`labeled 39*/72 mer or 39*/8oxoG72 mer  
 and pol  WT and mutants to be tested. 
The reaction, the reaction stop, the loading and the visualizing were done in 
the same way as the DNA polymerase assay. (For details see 4.10.) 
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5 Results 
5.1 Rationale to design in silico mutants of DNA polymerase   
The aim of this study was to scientifically verify predictions made based on 
the „metasystem PerZan”. Therefore, the structure and function of pol  was 
studied, as well as its interaction with DNA. Taking this as a starting point, the 
following 20 different mutations in the nucleotide sequence of pol  were 
proposed (see Figure 1A). None of the following mutants have been published 
so far. This was an important perquisite to guarantee that the „metasystem 
PerZan” with Karsten Knut Panzer could not compare their analysis with the 
already existing literature. Furthermore the argumentation made below for the 
20 in silico mutants was not given to Karsten Knut Panzer before he made his 
analysis by the „metasystem PerZan”. 
Three mutations were done in the N-terminal of pol  (aa 1-241) where the 
BRCT (aa 36-126) domain is located (Garcia-Diaz et al., 2005; Garcia-Diaz et 
al., 2002). This domain is likely involved in protein-protein interactions 
between factors required for the cellular response to DNA damage (Lee et al., 
2004): 
 Mutation 1: A9V 
 Mutation 2: A9D 
 Mutation 3: P78F 
Binding of the DNA by the pol and the 8kDa (aa 242-327) domains result in a 
90° bend of the DNA duplex that causes the DNA downstream of the gap to 
rotate out, exposing the 3’ end of the primer. The bend is facilitated by a 
stacking the interaction between Trp 274 and the first base of the template 
downstream of the gap (Garcia-Diaz et al., 2004). Therefore, this amino acid 
was mutated: 
 Mutation 4: W274Y 
The catalytic domain of pol  makes limited contacts with the DNA duplex, 
only interacting with the first two base pairs upstream of the primer terminus.  
On the other hand pol  makes several contacts with the DNA downstream of 
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the gap, mainly through the 8kDa domain and to the downstream primer. The 
5’ terminal phosphate on the downstream primer is buried in a positively 
charged pocket that also constitutes the dRP lyase active site (Garcia-Diaz et 
al., 2004). The dRP lyase activity can remove a 5’ terminal sugar-phosphate 
(dRP) group (Garcia-Diaz et al., 2001). The next four mutations were 
suggested in this positively charged pocket: 
 Mutation 5: R308E 
 Mutation 6: K312R 
 Mutation 16: R308K 
 Mutation 17: R275H 
Furthermore a helix-hairpin-helix (HhH) motif is located in the 8kDa domain, 
interacts with the backbone of the downstream primer and contains the 
catalytic residue (Lys 312) for the dRP lyase activity (Garcia-Diaz et al., 
2004). Two mutations were proposed in this HhH: 
 Mutation 8: E315P 
 Mutation 9: K312V 
The conformational changes of pol , that the enzyme likely undergoes as it 
binds the substrates and proceeds through a catalytic cycle, result in correct 
positioning of the three catalytic carboxylate residues that coordinate two 
divalent metal ions (Garcia-Diaz et al., 2005). These metals participate in 
catalysis in a manner universally utilized by pols (Steitz, 1999). The next 
mutation was made in one of the amino acid that carries one of these three 
catalytic carboxylate residues: 
 Mutation 19: D490K 
An other HhH motif in pol  is conserved in the fingers (aa 328-385) and 
interacts with the primer strand. This motif is common to several DNA binding 
proteins and confers a sequence-independent interaction with the DNA 
backbone (Garcia-Diaz et al., 2004). Therefore the mutation 7 was done at 
the position 349: 
 Mutation 7: A349P 
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In the binary complex of pol , the N-helix is in the thumb (aa 494-575) in a 
location similar to that seen in the ternary complex of pol , suggesting that 
pol  is in a closed conformation, even though no dNTP is bound to the active 
site of the pol (Garcia-Diaz et al., 2004). The mutation in the thumb was as 
follows: 
 Mutation 10: R517H 
An interaction between Arg 420 and Lys 422 of the palm subdomain and Asp 
574 of the thumb subdomain in pol  is not present in pol . This interaction 
could help to maintain the closed conformation of the thumb of pol , even 
when dNTP is absent (Garcia-Diaz et al., 2004). Therefore the following 
mutations were chosen: 
 Mutation 11: R420K 
 Mutation 12: K422D 
 Mutation 13: D574E 
The thumb - 8kDa interaction in pol  seems to be medicated by a contact 
between Trp 575 and Asn 284 not observed in pol  (Garcia-Diaz et al., 
2004):  
 Mutation 14: W575F 
 Mutation 15: N284T 
Interestingly, pol  Tyr 267 hydrogen bonds to the phosphate of the 5’ 
nucleotide. This interaction is absent in pol  and probably all other human 
family X enzymes. The presence of this additional interaction with the 5’ 
phosphate might account for the differences observed between pol  and pol 
 regarding processing of a short gap and strand displacement (Garcia-Diaz 
et al., 2004): 
 Mutation 18: Y267W 
At last the following blind mutation was proposed: 
 Mutation 20: L161Y 
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5.2 Analysis of 20 DNA polymerase   mutants by the 
„metasystem PerZan” 
The 20 pol  mutants generated in silico, as described above, were analyzed 
by Karsten Knut Panzer on the basis of his „metasystem PerZan”. According 
to this, the mutants were subdivided into 5 classes of mutational success, of 
which four mutants were subsequently chosen: 
Table 1: 20 DNA pol   mutants analyzed by the „metasystem PerZan”  
Predictions according to the „metasystem 
PerZan” 
DNA polymerase  
mutations 
+++++ „best mutation success over 5 
levels” 
K312V1 
++++ „extrem good mutation success over 
4 levels” 
A9V, A9D, W274Y, R517H, 
Y267W1, L161Y 
+++ „good mutation success over 3 
levels” 
P78F, R308E, N284T 
++ „weak mutation success over 2 
levels” 
A349P1, R420K 
 „no mutation success” K312R, E315P, K422D, 
D574E, W575F, R308K, 
R275H, D490K1 
1The bold mutations were chosen for further work. 
„No mutation success” means here that there is no visible change observed in 
the iGENE VISION. Functionally this means that these mutants are the most 
different ones when compared to the WT enzyme. The K312V, Y267W, 
A349P and D490K from four different levels were chosen for further work. The 
aim was to have a closer look to four levels of the „metasystem PerZan”. 
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5.3 Characterization of the four DNA polymerase   mutants 
 after purification 
After the three main steps of purification (PC, HisTrap, HiTrap) the pol  
mutants A349P, K312V, Y267W and D490K were characterized by SDS-
PAGE, by western blot analysis and for nuclease contamination. Figure 2A 
shows that the four enzymes were all over 90% pure. The western blot 
analysis showed that all enzymes are indeed pol  (Figure 2B) and finally the 
nuclease assay showed the absence of contaminating nucleases in the 
amount range (25-200 ng) used in this work (Figure 2C). 
 
 
 
 
 
Figure 2: Characterization of the four DNA polymerase   mutants. The 
experiments were performed as outlined in Materials and Methods. A) SDS-PAGE 
and coomassie staining, B) Western blot analysis, C) Nuclease assay. 
A 
B 
C 
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Pol  % 
WT 100 
K312V 96 
Y267W 71 
A349P 24 
D490K < 0.1 
5.4 Titration of the four DNA polymerase   mutants on a 
 39/72 mer primer/template 
First the four pol  mutants and the WT were titrated over a control 
undamaged 39/72 mer primer/template. The results showed that K312V had a 
similar DNA synthesis pattern as the WT, while the Y267W and the A349P 
showed reduced incorporation. The D490K was catalytically inactive (Figure 
3A). The quantified products are documented in Figure 3B. With 50 ng of the 
enzyme the pol  mutant K312V lead to 96% of activity in comparison to the 
WT, Y267W showed 71%, A349P 24% and D490K had less than 0.1% 
(Figure 3C). 
 
 
B 
  
 
Figure 3: Titration of the four DNA polymerase   mutants on a 39/72 mer 
primer/template. The experiments were performed as outlined in Materials and 
C 
A 
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Methods. A) Increasing amounts of pol  were titrated with a constant amount of 
dNTPs and control primer/template and quantified with Adobe Photoshop CS3 as 
seen in B). Summarized in C) is the resulting order of their activities. 
5.5 Titration of the four DNA polymerase   mutants on a 
 39/8oxoG72 mer primer/template 
Next it was of interest to test how the pol  mutants behave over a 
39/8oxoG72 mer primer/template. It was the same primer/template as used in 
Figure 3 but with an 8-oxo-G lesion immediately after the primer. 
It is known that pol  is a protection shield against exactly these oxidative 
damages, since it can incorporate the correct C opposite an 8-oxo-G and thus 
corrects the mistakes made by the replication machinery, which often 
incorporates the wrong A opposite an 8-oxo-G. Pol  allows the correct 
incorporation of dCTP opposite an 8-oxo-G template 12-fold more efficiently 
than the incorrect dATP (Maga et al., 2007). Therefore it was of interest to test 
the four pol  mutants on this 8-oxo-G lesion. 
The data in Figure 4 showed that the pol  mutants K312V and Y267W 
produced more incorporation products than A349P and that D490K was again 
inactive. The data were again quantified as in Figure 3 and showed that the 
hierarchy with the 8-oxo-G template corresponds to the control template 
(compare Figure 3C and 4C). 
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Pol  % 
WT 100 
K312V 83 
Y267W 82 
A349P 61 
D490K  < 0.1 
B 
 
 
Figure 4: Titration of the four DNA polymerase   mutants on a 39/8oxoG 72 mer 
primer/template. The experiments were performed as outlined in Materials and 
Methods. A) An increasing amount of pol  was titrated with a constant amount of 
dNTPs and 8-oxo-G primer/template and quantified with Adobe Photoshop CS3 as 
seen in B). Summarized in C) is the resulting order of their activities. 
5.6 Titration of the four DNA polymerase   mutants on 39/72 
 mer and on 39/8oxoG72 mer primer/templates 
The next set of experiments was performed side by side by testing the 
enzyme on a control and on an 8-oxo-G template. Again, the samples were 
prepared as described before, but to make sure that a comparison is possible, 
the same master mix was used for both primer/templates tested. The master 
mix was divided in two and in one part the control template and in the other 
part the template with the 8-oxo-G lesion was added. Then the reaction was 
started by adding 9 μl of this reaction mix to pol  dilutions and the further 
procedure was like before. 
The data suggested (Figure 5A) that in each case synthesis over 8-oxo-G was 
reduced (Figure 5B). When the results were quantified, the WT pol  showed 
78% of activity over the 8-oxo-G template when compared to the control 
template. The mutants showed 65% for K312V, 62% for Y267W and 53% for 
A349P. Again the D490K was inactive. In summary the same hierarchy was 
evident as already observed in Figure 3 and 4 being WT > K312V > Y267W > 
A349P >>> D490K. 
C 
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Pol    WT K312V Y267W A349P  D490K 
control 
template 
100 100 100 100 < 0.1 
8-oxo-G 
template 
% 
78 65 62 53 < 0.1 
 
Figure 5: Titration of the four DNA polymerase   mutants on 39/72 mer and on 
39/8oxoG72mer primer/templates. The experiments were performed as outlined in 
Materials and Methods. A) An increasing amount of pol  enzyme was titrated with a 
constant amount of dNTPs, control and 8-oxo-G primer/template and quantified with 
Adobe Photoshop CS3. Summarized in B) is the order of activities shown. 
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5.7 Titration of dNTP’s in the presence of a constant amount 
 of the four DNA polymerase   mutants on 39/72 mer and 
 on 39/8oxoG72 mer primer/templates 
So far, the amount of dNTPs was kept constant and the pol  mutants and the 
WT were titrated. With these experiments the same order in the activity was 
always showed, namely that K312V is more active than Y267W. These two 
have apparently more activity than A349P and with D490K no activity could 
be seen (compare Figures 3C, 4C and 5B). In the following experiment 
dNTPs were titrated and the amount of enzyme was kept constant. 
1) Vmax is the maximal rate at which an enzyme catalyzes a reaction. It is 
expressed as the amount of product formed per minute. So the Vmax shows 
how fast pol  incorporates its substrat (dNTPs). A low Vmax means that the 
enzyme incorporates its substrate slowly. 
2) Km represents the substrate concentration at half of Vmax of the enzyme. It 
is a measurement of the apparent affinity of the enzyme for the substrate. In 
other words, it indicates how well the substrate is binding the enzyme. 
Therefore with a low Km the affinity for the substrate is high. 
3) Kcat is a measurement of the turnover of the enzyme. It says which amount 
of dNTP is incorporated per minute. 
4) Kcat/Km describes the relative specificity of a fixed amount of the enzyme for 
its substrate being the parameter showing the enzyme efficiency. 
Since the main interest was to analyse the pol  efficiency, the Kcat/Km were 
finally compared. The mutant K312V showed a higher Kcat/Km value than the 
WT (Figure 6B) while Y267W was about equal. The Kcat/Km value of the 
A349P was 10 times reduced compared to the WT. The D490K was again 
inactive. In summary with these experiments a different hierarchy was 
observed, being K312V > Y267W > WT >> A349P >>> D490K. 
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B 
Pol  template Km (μM) Kcat (min-1) 
Vmax 
(μMmin-1) 
Kcat/Km 
(min-1μM-1) 
control 5.6x10-3 0.41 3.3x10-3 73.25 
WT 
8-oxo-G 4.0x10-3 0.35 2.8x10-3 87.39 
control 1.3x10-3 0.27 2.2x10-3 210.61 
K312V 
8-oxo-G 0.9x10-3 0.26 2.1x10-3 301.35 
control 1.6x10-3 0.12 1.0x10-3 73.13 
Y267W 
8-oxo-G 1.0x10-3 0.11 0.9x10-3 111.94 
control 19.1x10-3 0.14 1.1x10-3 7.33 
A349P 
8-oxo-G 46x10-3 0.11 1.0x10-3 2.39 
control 
not 
applicable 
not 
applicable 
not 
applicable 
not 
applicable 
D490K 
8-oxo-G 
not 
applicable 
not 
applicable 
not 
applicable 
not 
applicable 
 
Figure 6: Titration of dNTP`s in the presence of a constant amount of the four 
DNA polymerase   mutants on 39/72 mer and on 39/8oxoG72 mer 
primer/templates. The experiments were performed as outlined in Materials and 
Methods. A) Different amounts of dNTPs were titrated with a constant amount of pol 
 on a control and an 8-oxo-G primer/template and quantified with Adobe Photoshop 
CS3. Summarized in B) are Km, Kcat, Vmax and Kcat/Km.  
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5.8 Single nucleotide dCTP and dATP titrations of the four 
 DNA polymerase   mutants on 39/72 mer and on 
 39/8oxoG72 mer primer/templates 
The experiments so far always contained the four dNTPs. In the final 
experiment only dCTPs and dATPs were tested individually. For each reaction 
6 different dCTP and dATP concentrations were tested with a constant 
amount of pol . When the bias of correct C versus incorrect A incorporation 
was tested a novel hierarchy appeared, being A349P > WT > Y267W> K312V 
>>>D490K, which is the exact opposite observed so far (with the exception of 
the inactive mutant D490K). In this experiment, in which only a single dNTP 
was tested, the hierarchy changed in contrast to the synthesis tested with the 
complete set of four nucleotides. 
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B 
Pol  dNTPs template 
Km  
(μM) 
Kcat  
(min-1) 
Vmax 
(μMmin-1) 
Kcat/Km 
(min-1μM-1) C:A 
control 2.1x10-3 0.1 0.8x10-3 48.57 
dCTP 
8-oxo-G 2.2x10-3 0.1 0.8x10-3 45.33 
control not applicable 
WT 
dATP 
8-oxo-G 1.4x10-3 0.05 0.9x10-3 78.91 
2.60 
control 1.3x10-3 0.19 1.6x10-3 146.04 
dCTP 
8-oxo-G 1.3x10-3 0.17 1.4x10-3 129.67 
control not applicable 
K312V 
dATP 
8-oxo-G 0.1x10-3 0.08 0.6x10-3 618.71 
0.33 
control 2.7x10-3 0.1 0.8x10-3 37.13 
dCTP 
8-oxo-G 1.4x10-3 0.1 0.9x10-3 72.05 
control not applicable 
Y267W 
dATP 
8-oxo-G 0.7x10-3 0.06 0.48x10-3 87.68 
1.25 
control 1.4x10-3 0.11 0.9x10-3 78.91 
dCTP 
8-oxo-G 2.2x10-3 0.11 0.9x10-3 50.21 
control not applicable 
A349P 
dATP 
8-oxo-G 1.3x10-3 0.06 0.5x10-3 42.21 
3.13 
control 
not 
applicable 
not 
applicable 
not 
applicable 
not 
applicable 
dCTP 
8-oxo-G 
not 
applicable 
not 
applicable 
not 
applicable 
not 
applicable 
control not applicable 
D490K 
dATP 
8-oxo-G 
not 
applicable 
not 
applicable 
not 
applicable 
not 
applicable 
 
 
Figure 7: Single nucleotide dCTP and dATP titrations of the four DNA 
polymerase   mutants on 39/72 mer and on 39/8oxoG72 mer primer/templates. 
The experiments were performed as outlined in Materials and Methods. A) 
Increasing amounts of dCTP and dATP were titrated with a constant amount of pol  
on control and on 8-oxo-G primer/templates and quantified with Adobe Photoshop 
CS3. The values were summarized in B). The ration of C to A (last column) shows 
again the hierarchy: A349P > WT > Y267W >> K312V >>> D490K. 
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6 Discussion 
 
The aim of this thesis was to scientifically verify predictions made by the 
„metasystem PerZan”. 20 pol  mutants, generated in silico, were analyzed by 
Karsten Knut Panzer with his „metasystem PerZan”. According to this, the 
mutants were subdivided into 5 classes of mutational success, whereof four 
different mutants have been chosen, being A349P, K312V, Y267W and 
D490K. The pol  mutant protein were generated by site-directed 
mutagenesis, transformed and expressed in E. coli and finally purified. These 
four pol  mutants were subjected to scientific verification. In the starting 
experiments pol  WT and mutants were titrated and analyzed over 39/72 mer 
and 39/8oxoG72 mer primer/templates. Firstly, on a control primer/template it 
was found that the pol  mutant K312V achieved 96% of activity in 
comparison to the WT, Y267W 71%, A349P 24%. The D490K mutant was as 
expected inactive (< 0.1%). Secondly, the pol  mutants were titrated over a 
template containing an 8-oxo-G lesion. It was found that K312V arrived 83% 
of activity in comparison to the WT, Y267W 82% and A349P 61%. D490K 
again was inactive. Thirdly, each of the four mutants and the WT pol  were 
titrated over a control and an 8-oxo-G primer/template in the same gel. 
Furthermore dNTP’s were titrated in similar experiments. These experiments 
suggested a similar hierarchy, namely that K312V was more active and 
efficient than Y267W and these two more than A349P. The mutant D490K 
was inactive in all experiments. This was the same order as the „metasystem 
PerZan” has predicted.  
Furthermore it is known that pol  can incorporate a correct dCTP opposite an 
8-oxo-G site 12 times more efficiently than the wrong dATP (Maga et al., 
2007). According to this observation the mutants were tested in their activity 
to incorporate the single nucleotides dCTP and dATP. By analyzing the 
Kcat/Km, we found that the A349P mutant was more efficient than Y267W. 
Both were more efficient than K312V and with D490K again no incorporation 
was observed. The so far weak mutant A349P was incorporating a correct 
dCTP better opposite 8-oxo-G than all the other mutants and also the WT. In 
45
this single nucleotide incorporation experiments another hierarchy was 
observed, not corresponding to the predictions of the „metasystem PerZan”.  
From these studies it was conclude that the „metasystem PerZan” was right in 
predicting the mutation order as long as the experiments were done with all 
four nucleotides. The „metasystem PerZan” was however overstrained when 
asked for specific parameters such as Vmax, Km, Kcat and Kcat/Km. To proof the 
principle further, one could chose four different mutants from the same level of 
„mutation success” predicted by the „metasystem PerZan”. It would then be 
interesting to see if such mutants have the same activity and efficiency.  
In conclusion, the „metasystem PerZan” is more than just a fantasy and might 
give an overview, but the current data cannot yet admit that the proof of 
principle has been achieved for the „metasystem PerZan”. For this 
experiments with more mutants and other test systems would be required. 
They could e.g. include for K312V dRPlyase assays, for Y267W gap filling 
assays and for A349P DNA binding assays. 
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